SELECT \"nct\", \"author\", \"year\", \"pubmed_id\", \"trial_phase\", \"treatment_regimen\", \"class_of_ici\", \"name_of_ici\", \"monotherapy_combination\", \"type_of_combination\" FROM public.\"clinical_trials\" WHERE \"trial_phase\" = 'Phase 2' AND \"class_of_ici\" = 'PD1' AND \"cancer_type\" = 'Breast' AND \"type_of_combination\" = 'monotherapy' AND \"is_pd_l1_positivity_inclusion_criteria\" = 'yes' AND \"is_any_other_biomarker_used_for_inclusion\" = 'no'",
  "answer": "Phase 2 PD-L1 monotherapy trials in Breast cancer are available, with their regimens listed.",
  "assumptions": "Assuming 'PD-L1' is mapped to 'PD1' in the class_of_ici column and 'monotherapy' is specified in type_of_combination."
}
</think>

{
  "sql": "SELECT \"nct\", \"author\", \"year\", \"pubmed_id\", \"trial_phase\", \"treatment_regimen\", \"class_of_ici\", \"name_of_ici\", \"monotherapy_combination\", \"type_of_combination\" FROM public.\"clinical_trials\" WHERE \"trial_phase\" = 'Phase 2' AND \"class_of_ici\" = 'PD1' AND \"cancer_type\" = 'Breast' AND \"type_of_combination\" = 'monotherapy' AND \"is_pd_l1_positivity_inclusion_criteria\" = 'yes' AND \"is_any_other_biomarker_used_for_inclusion\" = 'no'",
  "answer": "Phase 2 PD-L1 monotherapy trials in Breast cancer are available, with their regimens listed.",
  "assumptions": "Assuming 'PD-L1' is mapped to 'PD1' in the class_of_ici column and 'monotherapy' is specified in type_of_combination."
}